FHA-17940-37522
2 vaccinations
11 coded responses
22 check-ins
11 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 948 / CA
- Registered
- 2021-02-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-18
Registered in v-safe
-
2021-02-18
Dose 1 — Moderna
- 2021-02-18
-
2021-02-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-02-20
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-21
Survey response — days 1–6 daily, dose 1MedDRA: Fatigue, Pre-existing disease — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Chronic fatigue syndromeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-22
-
2021-02-23
Survey response — days 1–6 daily, dose 1MedDRA: Fatigue — Feeling: Fair · Fatigue or tirednessFree text: Fatigue the usual level for me due to chronic fatigue syndromeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-25
Survey response — day 7, dose 1MedDRA: Condition aggravated, Fatigue, Pre-existing disease — Feeling: Fair · Fatigue or tirednessFree text: Typical for me re chronic fatigue syndrome I seeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-12
-
2021-03-18
Dose 2 — Moderna
-
2021-03-18
Survey response — day 0, dose 2MedDRA: Pre-existing disease — Feeling: Fair · Fatigue or tirednessFree text: I have chronic fatigue syndrome and I have been experiencing moderate fatigue within my usual range before I got my shot today at 2:30pm California. Since then I have not experienced an increase in fatigue.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-19
Survey response — days 1–6 daily, dose 2MedDRA: Asthenia — Feeling: Poor · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Felt weak. Symptoms worse than my usual range of chronic fatigue. Improved about 24hrs after the shot. Still in the moderate range but closer to the severe range.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-21
Survey response — days 1–6 daily, dose 2MedDRA: Chronic fatigue syndrome — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Usual symptoms for me related to chronic fatigue syndromeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-23
Survey response — days 1–6 daily, dose 2MedDRA: Adverse reaction — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessFree text: Symptoms seem a little worse than my usual, but still in the moderate rangeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-24
Survey response — days 1–6 daily, dose 2MedDRA: Fatigue — Feeling: Fair · Site: Itching · Fatigue or tirednessFree text: Somewhat more fatigued than yesterdayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-25
Survey response — day 7, dose 2MedDRA: Adverse reaction — Feeling: Fair · Fatigue or tirednessFree text: About my usual level, mid range moderateMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-01
- 2021-04-08
-
2021-04-16
Survey response — day 28, dose 2MedDRA: Fatigue — Feeling: PoorFree text: More fatiguedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-22
- 2021-05-01
- 2021-06-17
-
2022-03-20
Survey response — 12 months, dose 2MedDRA: Dizziness, Mast cell activation syndrome, Vertigo — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Mast Cell Activation Syndrome; dizzyness and vertigoMedDRA releases: 2024-11 · check-in free text available
-
2022-03-20
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-18 | Moderna | |
| 2 | 2021-03-18 | Moderna |
Call center
1 call center case
1 unsuccessful
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Chronic fatigue syndrome
Systemic reaction (other): Fatigue the usual level for me due to chronic fatigue syndrome
Release 4 — day 7, dose 1
Systemic reaction (other): Typical for me re chronic fatigue syndrome I see
Release 5 — day 0, dose 2
Systemic reaction (other): I have chronic fatigue syndrome and I have been experiencing moderate fatigue within my usual range before I got my shot today at 2:30pm California. Since then I have not experienced an increase in fatigue.
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Felt weak. Symptoms worse than my usual range of chronic fatigue. Improved about 24hrs after the shot. Still in the moderate range but closer to the severe range.
Systemic reaction (other): Usual symptoms for me related to chronic fatigue syndrome
Systemic reaction (other): Symptoms seem a little worse than my usual, but still in the moderate range
Systemic reaction (other): Somewhat more fatigued than yesterday
Release 6 — day 7, dose 2
Systemic reaction (other): About my usual level, mid range moderate
Release 7 — day 28, dose 2
Symptoms: More fatigued
Release 11 — 12 months, dose 2
Symptoms: Mast Cell Activation Syndrome; dizzyness and vertigo
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dizziness | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Mast cell activation syndrome | · | · | ✓ |
| SD | Vertigo | · | · | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Asthenia | ✓ | ✓ | ✓ |
| SRO | Chronic fatigue syndrome | ✓ | ✓ | ✓ |
| SRO | Condition aggravated | ✓ | · | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release